Ben Barron-Millar

Ben Barron-Millar is a medical writer and analyst currently working at Genesis Research. Prior to this, they worked as a postdoctoral research associate at Newcastle University from January 2015 to April 2021. Ben's research focused on immunotherapy for the musculoskeletal system. Ben was also part of the EMINENT MRC project grant.

Ben Barron-Millar has a PhD in Molecular Biology from Newcastle University, an MRes in Immunobiology from Newcastle University, and a Bachelor's degree (Hons) in Microbiology, General from the University of Dundee.

Ben Barron-Millar reports to Frank A. Corvino, CEO. Some of their coworkers include Chris Pashos - Chief Medical Officer & Head, Research Partnerships, David Cork - Director, Evidence Strategy, and Wen-Hsing Wu - Senior Scientist, Real World Evidence.